I collaborate with experts in the development and launch of pharmaceuticals that are used to treat rare medical conditions. I have successfully launched 10 ultra-orphan drugs, working with 14 different ultra-orphan/orphan medications. My expertise is in the biotech industry, specifically in US global market access strategy planning and value messaging and execution, business development, channel management, and strategic alliances. C-Suite leaders and executives rely on me to advance market access, market growth and patient support. Below are highlights of my career accomplishments and specialties:
Designed and developed a flexible and scalable channel strategy and distribution model, including third party logistics and specialty pharmacies to provide rapid access for patients.
Developed commercial and government payer strategies and objectives to ensure favorable payer coverage.
Created an innovative model to maximize strategic alliances for rapid payer acceptance, including a value proposition and messaging that minimized payer restrictions.
Implemented and optimized patient support services, including HUB model design and created a hybrid model to provide superior patient access.
Spearheaded U.S. portfolio pricing evaluation and global insights to successfully minimize payer utilization management.
Specialties:
US and Global Experience| Product Launch | Market Access | Distribution and Trade | Medicare and Medicaid | Contracting and Pull Through | Immunology | Oncology | Hereditary Angioedema| Gastroenterology | Genetics | Cardiology | Pulmonology | Neurology | Nephrology | Endocrinology | Infectious Disease | Commercial Operations| Growth Strategies | Business Development | Sales